Trial Profile
Open label study of zonisamide in the treatment of epilepsy in patients with mental retardation / developmental disabilities
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Epilepsy; Mental retardation
- Focus Therapeutic Use
- 02 Aug 2007 New trial record.